Transdifferentiation is defined as the experimentally induced direct conversion of one cell lineage into another. It is typically achieved by ectopic expression of small sets of cell type--specific transcription factors and has been used to convert fibroblasts into a variety of cell types, including myoblasts, cardiomyocytes, hepatocytes and neural cells^[@R1]^. Recently, a more general lineage conversion approach has been developed that uses transient expression of iPSC-inducing transcription factors. For example, transient expression of OKSM in fibroblasts was reported to give rise to iNSCs, pancreatic progenitors, cardiomyocytes, hepatocytes, and endothelial cells when pluripotency-inducing signaling (LIF/Stat3) is removed and cells are cultured in the presence of lineage-specifying extracellular cues^[@R2]--[@R8]^. These studies suggested that transient expression of pluripotency-associated transcription factors generates a developmentally plastic state that is amenable to transdifferentiation into other cell types by exposure of cells to different environmental signals^[@R9]^. Several lines of evidence suggested that this process does not involve formation of a transient iPSC state and subsequent differentiation. For example, mouse embryonic fibroblasts (MEFs) subjected to OKSM transdifferentiation protocols failed to show activation of transgenic pluripotency reporters such as *Nanog-GFP* or *Oct4-GFP* ^[@R2],[@R4],[@R7]^. Moreover, the kinetics of transdifferentiation was shorter than that of induced pluripotency when using certain culture conditions, suggesting that iPSCs could not have formed^[@R2],[@R4],[@R7]^. Lastly, an alternative transdifferentiation cocktail, Brn4, Klf4, Sox2 and c-Myc (BKSM), also generated iNSCs without apparent production of iPSCs^[@R3]^.

The use of OKSM in both induced pluripotency and transdifferentiation protocols raises the question of how these transcription factors induce such different cell fates. We therefore sought to compare and contrast reprogramming into iPSCs by OKSM and transdifferentiation to iNSCs by either OKSM or BKSM.

Reprogrammable MEFs (rep-MEFs), which carry the *tetOP-OKSM* allele in the *Col1a1* locus, the *M2rtTA* transgene in the *Rosa26* locus and an *EGFP* reporter in the endogenous *Oct4* locus (*Oct4-GFP*)^[@R10]^, exposed to doxycycline (dox) gave rise to iPSCs after 1--2 weeks in conventional embryonic stem cell (ESC) medium (serum and LIF)([Fig. 1A, B](#F1){ref-type="fig"}). In contrast, treatment of rep-MEFs with dox in medium containing the NSC cytokines FGF and EGF but lacking serum/LIF (NSC medium) yielded clusters of cells that morphologically and phenotypically resembled NSC colonies ([Fig. 1A, B](#F1){ref-type="fig"}). For example, cellular projections emanating from iNSC-like colonies suggested formation of neurites, which are typically seen in brain-derived NSC cultures ([Fig. 1B](#F1){ref-type="fig"}). We picked and expanded individual colonies in NSC medium, generating stable clonal cell lines. Immunofluorescence staining and microarray gene expression analysis of these cell lines revealed upregulation of key NSC markers, such as Sox1, Sox2, Nestin and Glast, at levels similar to those of brain-derived NSCs, whereas MEF-related genes, including *Col5A1* and *Fbln5*, were markedly downregulated ([Fig. 1C, D](#F1){ref-type="fig"} and [Supplementary Fig. 1A](#SD1){ref-type="supplementary-material"}). Unsupervised clustering, correlation and functional annotation analyses of global mRNA expression data further showed that these iNSC-like cells are highly similar to brain-derived NSCs but different from MEFs or iPSCs/ESCs ([Supplementary Fig. 1B--D](#SD1){ref-type="supplementary-material"}). Cultures expanded from single iNSC-like colonies could differentiate into Tuj1^+^ neurons and GFAP^+^ astrocytes, demonstrating multilineage differentiation potential ([Fig. 1E](#F1){ref-type="fig"}). Together, these results show that pulsed OKSM expression with our reprogrammable system in the presence of NSC inductive cytokines produces authentic iNSCs (OKSM-iNSCs) that exhibit multipotency, self-renewal potential and a high similarity to brain-derived NSCs.

We previously showed that the formation of stable iPSCs requires a minimum of 8--10 days of OKSM expression under conventional culture conditions^[@R11]^. To determine the minimal time needed to generate iNSCs, we induced rep-MEFs with dox in NSC medium for different lengths of time, followed by dox withdrawal before counting iNSC colonies at day 19. OKSM expression was required for at least 8 days to detect iNSC colonies, as determined by staining for Sox1 ([Fig. 1F, G](#F1){ref-type="fig"}). The apparent similarity in temporal factor requirement between iNSC and iPSC generation prompted us to ask whether iPSC colonies could form in NSC medium, a condition that is incompatible with long-term culture of iPSCs. Notably, forced expression of OKSM in rep-MEFs consistently gave rise to rare Oct4-GFP^+^ iPSC-like cells (0.2% of total cell population) in this differentiation-stimulating condition ([Fig. 1H, I](#F1){ref-type="fig"}). Unlike brain-derived NSCs or OKSM-iNSCs, these colonies co-expressed Oct4 and Nanog, ruling out the possibility that they were primitive neurectodermal cells that continued to express Oct4 upon exit from pluripotency^[@R12]^ ([Supplementary Figs. 1E](#SD1){ref-type="supplementary-material"}, [2A, B](#SD1){ref-type="supplementary-material"}). The iPSC-like colonies could be stably propagated in ESC medium in the absence of exogenous transgene expression (i.e., after dox withdrawal) and showed expression of the pluripotency-associated markers alkaline phosphatase, PECAM1, EpCAM and Nanog at levels that were comparable to ESCs, indicating self-renewal capacity and faithful molecular reprogramming to pluripotency ([Supplementary Fig. 2C--E](#SD1){ref-type="supplementary-material"}). Notably, the expanded iPSC-like clones contributed to coat-color chimeric mice and to their offspring upon injection into blastocyst embryos---a rigorous measure of pluripotency ([Fig. 1J](#F1){ref-type="fig"}). We conclude that forced OKSM expression overrides the requirement for serum and LIF/Stat3 signaling and counteracts differentiation-inducing signals (EGF, FGF), generating authentic, germline-competent iPSCs under adverse growth conditions.

These data raise the possibility that certain previously published transdifferentiation protocols using OKSM overexpression might have in fact generated transient iPSC cells that then differentiated into other cell lineages in response to extracellular cues. To test this hypothesis, we first examined the order of events in transdifferentiation by tracking cell surface markers by flow cytometry. During reprogramming toward iPSCs, MEFs first downregulate the fibroblast-associated marker Thy1 and then upregulate the pluripotency-associated marker SSEA1 at day 3, followed by EpCAM expression by day 6^[@R11],[@R13]^. We observed a similar downregulation of Thy1 and an upregulation of EpCAM in a fraction of cells (∼5%) at day 6 of OKSM expression under iNSC transdifferentiation conditions, although established iNSCs and brain-derived NSCs do not express EpCAM ([Supplementary Fig. 2F, G](#SD1){ref-type="supplementary-material"}). Analysis of SSEA1 expression was not informative because it is also expressed by NSCs^[@R14]^. These results show that OKSM-induced lineage conversion generates similar phenotypic intermediates as OKSM-induced pluripotency, despite very different extracellular stimuli.

Sorted EpCAM^+^ intermediates obtained after 6 days of OKSM expression in ESC medium give rise to rare dox-independent iPSC colonies, whereas EpCAM^−^ intermediates do not^[@R13]^. To prospectively determine whether these subpopulations can give rise to iNSCs, we sorted day 6 SSEA1^−^/EpCAM^−^, SSEA1^+^/EpCAM^−^ and SSEA1^+^/EpCAM^+^ intermediates generated in ESC medium and cultured them in either ESC or NSC medium without dox ([Fig. 1K, L](#F1){ref-type="fig"}). Only SSEA1^+^/EpCAM^+^ intermediates could produce transgene-independent iPSCs or iNSCs ([Fig. 1K, L](#F1){ref-type="fig"} and data not shown). These findings show that iPSCs and iNSCs originate from the same rare subpopulation of SSEA1^+^/EpCAM^+^ cells that emerge shortly after OKSM expression.

Considering that EpCAM^+^ intermediates typically give rise to Oct4-GFP^+^ iPSCs under ESC culture conditions^[@R13]^ and that rare Oct4-GFP^+^ cells emerge under NSC transdifferentiation conditions ([Fig. 1H, I](#F1){ref-type="fig"}), we next determined the fraction of nascent iNSC colonies that expressed the pluripotency gene *Oct4 in situ* over time using the same *Oct4-GFP* knock-in reporter. The majority of colonies forming at early time-points of OKSM expression (days 10--12) in NSC medium indeed contained small clusters of Oct4-GFP^+^ cells, whereas colonies at intermediate time points (days 17--22) consisted of Oct4-GFP^+^ clusters, iNSC-like clusters or a combination of both ([Fig. 1M, N](#F1){ref-type="fig"}). Oct4-GFP expression was entirely silenced upon picking and expansion of these iNSC-like colonies in NSC medium without dox (data not shown).

To accurately determine how many colonies expressed Oct4 before becoming iNSCs, we used cells carrying a 4-hydroxytamoxifen (4-OHT)-inducible *Oct4-CreER* allele in combination with a *Rosa26-loxSTOPlox-EYFP* (*R26-lsl-EYFP*) reporter cassette^[@R15]^ ([Fig. 2A](#F2){ref-type="fig"}). We first determined the specificity and sensitivity of this lineage tracing system for labeling pluripotent cells. To demonstrate that primitive Oct4^+^ neurectodermal cells^*12*^ are not labeled with this system *in vivo*, we treated pregnant females harboring *Oct4-CreER; R26-lsl-EYFP* bitransgenic embryos with tamoxifen at E8.5 and examined resultant fetuses at E13.5. We did not detect EYFP expression in the brains of five E13.5 fetuses or in derivative NSC cultures ([Fig. 2B](#F2){ref-type="fig"} and [Supplementary Fig. 3A, B](#SD1){ref-type="supplementary-material"}). However, we noticed strong EYFP signal in primordial germ cells in the genital ridge, which are known to express Oct4 at E8.5 ([Fig. 2B](#F2){ref-type="fig"}). To ensure that culture of brain-derived NSCs does not spuriously activate the *Oct4-CreER; R26-lsl-EYFP* reporter, we derived NSCs from the brains of E13.5 fetuses with this genotype and exposed cells to 4-OHT. These NSC lines remained EYFP^−^ regardless of whether 4-OHT was added to the culture ([Supplementary Fig. 3C](#SD1){ref-type="supplementary-material"}). Next, to confirm that short-term expression of OKSM does not directly activate the endogenous *Oct4* locus, we transduced *Oct4-CreER; R26-lsl-EYFP* MEFs with lentiviral vectors co-expressing tetOP-OKSM and M2-rtTA for 2 or 4 days before measuring EYFP expression by flow cytometry. No notable EYFP reporter signal was detected at these early time points ([Supplementary Fig. 4A](#SD1){ref-type="supplementary-material"}). We also failed to detect Oct4-GFP reporter expression after 2 and 4 days of OKSM expression ([Supplementary Fig. 4B](#SD1){ref-type="supplementary-material"}). In contrast, long-term induction of OKSM in *Oct4-CreER; R26-lsl-EYFP* MEFs in ESC or NSC media generated EYFP^+^ iPSCs in a 4-OHT-dependent manner ([Fig. 2C--E](#F2){ref-type="fig"}, [Supplementary Fig. 5A](#SD1){ref-type="supplementary-material"} and data not shown). EYFP^+^ iPSCs derived under NSC conditions expressed Nanog and Oct4, and they contributed to midgestation chimeras upon injection into blastocysts, demonstrating pluripotency ([Fig. 2C--E](#F2){ref-type="fig"} and [Supplementary Fig. 5B, C](#SD1){ref-type="supplementary-material"}). Based on these controls, we feel confident that this lineage tracing system and our culture conditions have high specificity and sensitivity, allowing us to determine whether nascent iNSCs go through a transient Oct4^+^ state. Similar to EYFP-labeled iPSCs produced in NSC medium ([Fig. 2C](#F2){ref-type="fig"}), all recovered Sox1^+^ iNSC colonies derived from OKSM-expressing *Oct4-CreER; R26-lsl-EYFP* MEFs were EYFP^+^ in the presence of 4-OHT, whereas no EYFP^+^ iNSC colonies were detected in the absence of 4-OHT ([Fig. 2F, G](#F2){ref-type="fig"}). EYFP^+^ iNSC clusters could be single-cell subcloned and propagated for over ten passages while maintaining NSC marker expression, indicating self-renewal capacity ([Fig. 2H, I](#F2){ref-type="fig"} and [Supplementary Fig. 6A--C](#SD1){ref-type="supplementary-material"}). These results show that all examined iNSCs generated under NSC conditions passed through a transient Oct4^+^ state.

We next applied the *Oct4-CreER* lineage tracing system to an alternative transdifferentiation protocol^[@R7]^ that gave rise to iNSCs but not iPSCs^[@R7]^ after only 4--5 days of Oct4 expression, coupled with constitutive expression of Sox2, Klf4 and c-Myc^[@R7]^. We were able to derive Sox1^+^ iNSC lines after only 4--5 days of OKSM expression, followed by 14--21 days of OKSM-independent growth, similar to a previous report^[@R7]^ ([Fig. 2J](#F2){ref-type="fig"} and [Supplementary Fig. 7A](#SD1){ref-type="supplementary-material"}). All examined Sox1^+^ iNSC colonies were also EYFP^+^ ([Fig. 2J](#F2){ref-type="fig"} and [Supplementary Fig. 7A](#SD1){ref-type="supplementary-material"}). This alternative transdifferentiation protocol uses a modified NSC medium containing KnockOut Serum Replacement (KOSR) and low amounts of serum, which are not included in conventional NSC medium^[@R7]^. We surmise that the presence of ascorbic acid in KOSR accelerates iPSC formation, as was shown previously^[@R16]^. thus explaining the faster appearance of iPSCs and derivative NSCs.

We used the modified transdifferentiation protocol in most subsequent experiments because of the higher recovery rate of iNSCs.

To rule out the possibility that our visual quantification of EYFP-marked cells missed single iNSCs or small iNSC colonies that underwent direct transdifferentiation, we repeated the experiment with MEFs harboring the *Oct4-CreER* allele in combination with a *R26-lsl*-DTA (Diphtheria Toxin fragment A) allele ([Supplementary Fig. 7B](#SD1){ref-type="supplementary-material"}). Expression of the *DTA* gene in 4-OHT-induced cells undergoing transdifferentiation or reprogramming is expected to ablate nearly all *Oct4*-expressing cells ([Supplementary Fig. 7B--D](#SD1){ref-type="supplementary-material"}). Using this system, we could not detect any Sox1^+^ iNSC colonies or Sox1^+^ single cells in 4-OHT-treated cultures compared to untreated cultures ([Fig. 2K](#F2){ref-type="fig"}), confirming that virtually all iNSCs pass through an *Oct4^+^* state.

To complement our Oct4 lineage labeling and ablation experiments with independent assays of pluripotency, we first examined retroviral silencing in iNSC cultures. Unlike most somatic cells, including NSCs, iPSCs efficiently silence retroviral transgenes due to the activity of *de novo* DNA methyltransferases^[@R11]^. We infected rep-MEFs with a retroviral vector constitutively expressing tdTomato ([Fig. 3A](#F3){ref-type="fig"}), purified tdTomato^+^ Rep-MEFs by FACS, and exposed them to dox and NSC medium ([Fig. 3A, B](#F3){ref-type="fig"}). Approximately 90% of iNSC colonies were tdTomato^−^, and ∼10% were tdTomato^+^ ([Fig. 3C](#F3){ref-type="fig"}). We believe that the latter colonies represent nascent hybrid iPSC--iNSC colonies that had not yet undergone complete retroviral silencing (see also [Fig. 1M](#F1){ref-type="fig"}). Notably, culture of sorted tdTomato^+^ MEFs in NSC medium without dox did not elicit silencing of retroviral transgenes ([Supplementary Fig. 8](#SD1){ref-type="supplementary-material"}). We previously showed that reprogramming of female fibroblasts to iPSCs reactivates the silenced X chromosome, and subsequent differentiation of the iPSCs results in random X inactivation^[@R17]^. To determine whether X chromosome reactivation occurs during iNSC induction, we sorted GFP^−^ cells from a mixed population of GFP^+^ and GFP^−^ female tail tip fibroblasts (TTFs) carrying an X-linked GFP reporter in a heterozygous configuration (i.e., mix of Xa^GFP^Xi and Xi^GFP^Xa cells). Thus, all sorted GFP^−^ TTFs carried the GFP transgene on the inactive X chromosome (Xi^GFP^Xa) ([Fig. 3D](#F3){ref-type="fig"}). Infection of these TTFs with lentiviruses expressing *tetOP-OKSM* (STEMCCA)^[@R18]^ and *M2rtTA* gave rise to iNSC colonies after 4--5 days of dox induction, followed by 2--4 weeks of dox-independent growth in the modified NSC medium. All Sox1^+^ iNSC colonies reactivated the silent X chromosome as judged by GFP expression in a fraction of cells ([Fig. 3E, F](#F3){ref-type="fig"}). GFP expression declined in some clones with continuous passaging of these iNSCs, possibly owing to silencing of the transgene or loss of the transgenic X chromosome ([Supplementary Fig. 9A](#SD1){ref-type="supplementary-material"}). However, we did not detect reactivation of GFP in sorted GFP^−^ TTFs after 14 days of culture in NSC medium in the absence of OKSM expression, indicating that the silenced X chromosome is not spuriously activated by culture in NSC medium ([Supplementary Fig. 9B](#SD1){ref-type="supplementary-material"}). Because the percentage of GFP^+^ cells varied among established iNSC clones, we confirmed reactivation of the silenced X chromosome in 7 clonally derived iNSC cultures by quantitative RT-PCR for an X-linked marker that distinguishes the maternal (*mus musculus*) and paternal (*mus castaneous*) X chromosome, respectively ([Supplementary Fig. 9C](#SD1){ref-type="supplementary-material"}). These data reinforce the interpretation that iNSCs transition through a pluripotent intermediate state with concomitant X reactivation before undergoing differentiation.

Next, we investigated whether interfering with genes involved in iPSC reprogramming affects the generation of iNSCs. *Nanog* is expressed in pluripotent cells but not in iNSCs ([Supplementary Fig. 1E](#SD1){ref-type="supplementary-material"}), and *Nanog* deficiency leads to a severe reduction in iPSC formation that can be rescued by exposure of cells to ascorbic acid^[@R19]^. *Nanog* knockout MEFs gave rise to 6--8 times more Sox1^+^ iNSC colonies in the presence of ascorbic acid compared to control cultures lacking ascorbate ([Fig. 3G, H](#F3){ref-type="fig"}). Ascorbate acts synergistically with the GSK3β inhibitor CHIR-99021 to increase iPSC formation efficiency^[@R20]^. Formation of iNSCs from wild-type MEFs was enhanced by exposure to both molecules compared to ascorbate alone, further demonstrating that iNSC generation responds to the same signaling pathways as iPSC formation ([Supplementary Fig. 10A, B](#SD1){ref-type="supplementary-material"}).

Finally, we studied a different iNSC transdifferentiation gene cocktail that did not yield iPSCs in ESC or NSC medium, namely Brn4, Klf4, Sox2 and c-Myc (BKSM)^[@R3]^. To ensure homogeneous expression of all four factors, we engineered a polycistronic lentiviral vector encompassing the coding regions for *Brn4*, *Sox2*, *Klf4* and *c-Myc* under the control of a dox-inducible promoter, akin to the OKSM/STEMCCA system^[@R18]^ ([Fig. 4A, B](#F4){ref-type="fig"} and [Supplementary Fig. 11A--C](#SD1){ref-type="supplementary-material"}). Infection of *Sox2-GFP* MEFs with lentiviral constructs expressing *tetOP-BKSM* and *M2rtTA* gave rise to Sox2-GFP^+^ iNSC-like colonies in the presence of dox and neural-inducing cytokines, in agreement with ref. [@R6] ([Supplementary Fig. 12A](#SD1){ref-type="supplementary-material"}). Of note, formation of iNSC clusters in conventional NSC medium required at least 12 days of BKSM expression, rather than 8 days with the OKSM cocktail, and we typically obtained ∼10 times fewer colonies (data not shown). BKSM-iNSCs could be propagated without dox, demonstrating independence from exogenous factor expression and self-renewal potential ([Fig. 4C](#F4){ref-type="fig"}, [Supplementary Fig. 12A](#SD1){ref-type="supplementary-material"} and data not shown). Accordingly, BKSM-iNSCs activated NSC markers, suggesting faithful molecular reprogramming towards an NSC-like state ([Fig. 4C, D](#F4){ref-type="fig"} and [Supplementary Fig. 12B, C](#SD1){ref-type="supplementary-material"}). Global gene expression analysis documented a high degree of similarity between OKSM-iNSCs, BKSM-iNSCs and brain-derived NSCs regardless of their origin from either fibroblasts or fetal brains, , whereas these samples were quite different from the starting MEF population ([Fig. 4F](#F4){ref-type="fig"} and [Supplementary Fig. 12B, C](#SD1){ref-type="supplementary-material"}).

In contrast to previous observations^[@R3]^, the BKSM combination generated iPSC-like colonies in both ESC and NSC media ([Supplementary Fig. 13A](#SD1){ref-type="supplementary-material"} and data not shown). As with OKSM-iPSCs derived in NSC medium, BKSM-iPSC-like clones activated key endogenous pluripotency genes, including *Nanog*, *Oct4* and *Zfp42*, when replated in ESC medium without dox, indicating transgene-independent self-renewal ([Fig. 4E](#F4){ref-type="fig"} and [Supplementary Fig. 13B](#SD1){ref-type="supplementary-material"}). The global transcriptional profile of BKSM-iPSC-like cells was highly similar to those of ESCs and OKSM-derived iPSCs ([Fig. 4F](#F4){ref-type="fig"} and [Supplementary Fig. 13B, C](#SD1){ref-type="supplementary-material"}). Lastly, BKSM-iPSCs supported the formation of teratomas and the generation of fetal and adult chimeras upon blastocyst injection, demonstrating pluripotency ([Fig. 4G](#F4){ref-type="fig"} and [Supplementary Fig. 13D, E](#SD1){ref-type="supplementary-material"}). Like BKSM-iNSCs, BKSM-iPSCs were recovered at a lower frequency and with delayed kinetics compared to OKSM-mediated iPSCs (data not shown), further supporting the notion of a linked process. Notably, infection of *Oct4-CreER; R26-lsl-EYFP* MEFs with lentiviral constructs expressing *M2rtTA* and *tetOP-BKSM* yielded exclusively EYFP^+^ iNSC colonies in the presence of 4-OHT, dox, EGF and FGF ([Fig. 4H, I](#F4){ref-type="fig"}). These BKSM-iNSC colonies continued to grow without dox and could be converted into iPSCs upon re-addition of dox ([Supplementary Fig. 14A--C](#SD1){ref-type="supplementary-material"}). Together, these results show that transdifferentiation into iNSCs using our polycistronic BKSM cassette inevitably passes through a transient Oct4^+^ state.

A key question is whether our observations extend to other types of lineage conversion using either pluripotency or lineage-specific factors. We examined activation of the *Oct4-CreER; R26-lsl-EYFP* reporter during OKSM-induced cardiomyocyte generation^[@R2]^ and *Ascl1/Brn2/Myt1l*-driven induced neuron (iN) formation^[@R21]^ from MEFs. OKSM-induced cardiomyocyte clusters exhibited rhythmic contractions and expression of cardiac troponin and activated the *Oct4-CreER; R26-lsl-EYFP* reporter in nearly all cases ([Fig. 4J, K](#F4){ref-type="fig"} and [Supplementary Fig. 15A, B](#SD1){ref-type="supplementary-material"}). By contrast, transdifferentiation of MEFs into iN-like cells did not activate the EYFP reporter, suggesting that passage through an *Oct4^+^* state may be specific to the use of pluripotency-related transcription factors ([Supplementary Fig. 15C--E](#SD1){ref-type="supplementary-material"}).

Here we show that pulsed expression of *OKSM* or *BKSM*, two gene cocktails, previously used for direct lineage conversion of fibroblasts into iNSCs, causes cells to pass through a transient Oct4^+^ state that silences retroviral transgenes and reactivates silenced X chromosomal genes in female somatic cells. We further demonstrate that forced OKSM and BKSM expression produces *bona fide* iPSCs under culture conditions that are incompatible with long-term culture of established pluripotent cell lines. These results imply that transdifferentiation protocols using pluripotency-associated factors often, if not always, involve reprogramming into short-lived iPSCs that rapidly differentiate into various lineages as determined by the extracellular environment ([Fig. 4L](#F4){ref-type="fig"}). Our results are consistent with previous findings that retroviral transgenes used to convert fibroblasts into iNSCs by brief OKSM expression are predominately silenced^[@R3],[@R7]^, whereas induced neural progenitor cells generated by forced expression of lineage-specific factors^[@R22]^ remain transgene-dependent. Our data might also explain the recent observation that cells generated through transdifferentiation with pluripotency factors exhibit chromosomal aberrations typically associated with pluripotent stem cell lines^[@R23]^.

Transient iPSC formation was ruled out in previous transdifferentiation studies owing to (i) the lack of *Nanog-GFP* or *Oct4-GFP* signal, (ii) the inability to derive iPSCs in culture conditions lacking LIF and containing differentiation-associated cytokines, and (iii) the different kinetics of direct lineage conversion and iPSC formation. We believe that the *Nanog-GFP* reporter may not be sufficiently sensitive to detect rare reprogramming events in heterogeneous bulk cultures. Consistent with this notion, previous studies recorded transient *Nanog* mRNA upregulation between days 6--8 of transdifferentiation by qPCR analysis even though no reporter signal was detected^[@R2],[@R4]^. Moreover, transdifferentiation experiments have often been performed under optimized culture conditions compared to control iPSC experiments, which may inadvertently facilitate fast yet transient iPSC formation. Indeed, several transdifferentiation supplements (e.g., CHIR99021, BMP4, bFGF, KOSR/ascorbic acid) strongly enhance and accelerate iPSC formation^[@R16],[@R20],[@R24]^. Accordingly, we could reduce the minimum number of days of OKSM expression required to derive stable iNSCs from 8 to 4 days by modifying the culture medium.

Our results show that the absence of LIF and the presence of differentiation-inducing cytokines (e.g., FGF, EGF) are not sufficient to block iPSC formation. Thus, forced transcription factor expression can effectively compensate for the lack of growth factors important for iPSC self-renewal and counteract culture conditions that normally trigger ESC/iPSC differentiation. This finding is reminiscent of the observation that forced expression of *Stat3* or *Nanog* bypasses the requirement for LIF signaling during ESC derivation and iPSC formation^[@R25],[@R26]^. We believe that our single-copy transgenic reprogramming system allowed us to increase the efficiency reprogramming through homogeneous expression of the four factors, facilitating mechanistic dissection of critical intermediate stages. By contrast, iNSC generation in some previous studies was extremely inefficient (1--3 iNSC colonies per infection with BKSM; 11 iNSC colonies per 130,000 infected cells or 0.008% with OKSM) and lengthy (3 weeks with OKSM, 4--6 weeks with BKSM expression)^[@R3],[@R7]^ , which was likely due to inefficient retroviral infection of fibroblasts or an inadequate expression stoichiometry of all four transgenes. The low efficiency of iNSC formation may also explain why iPSCs were not detected upon BKSM overexpression, whereas our use of a polycistronic, dox-inducible expression vector gave rise to iPSCs in ESC or NSC conditions, albeit at much lower efficiency than OKSM-mediated reprogramming.

Pluripotency factor--driven transdifferentiation has been proposed as a safer and more efficient alternative to induced pluripotency for therapeutic applications as it does not require lengthy iPSC differentiation protocols and avoids potential teratoma formation from rare undifferentiated cells. Our study highlights the practical importance of dissecting the mechanisms underlying transdifferentiation to determine whether cells transit through a pluripotent state. While transient passage through a pluripotent state is not expected to impact *in vitro* applications of this technology, it will be important to exclude the presence of residual iPSCs in potential clinical settings.

Materials and methods {#S1}
=====================

Cell culture {#S2}
------------

Mouse embryonic fibroblasts (MEFs) were cultured in DMEM supplemented with 1% Glutamax, 1% non-essential amino acids (NEAA), 1% Penicillin-Streptomycin, 0.5% β-mercaptoethanol (all from Life Technologies) and 10% FBS (Gibco). Mouse embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) were grown on irradiated MEFs (GlobalStem) in KO-DMEM medium (Life Technologies) supplemented with 15% FBS, 1% Glutamax, 1% NEAA, 1% Penicillin-Streptomycin, 1% β-mercaptoethanol, and 1000 Unit/ml LIF (purified in-house). Neural stem cells (NSCs) were cultured in DMEM/F12 (Life technologies) supplemented with 1XB27 and 1XN2 cell-supplements (Life Technologies), 0.01% Fraction V BSA 7.5% solution (Life Technologies), 1% Penicillin-Streptomycin and 10ng/ml bFGF (R&D) and 20ng/ml mouse EGF (Life Technologies) ("conventional NSC medium").

Generation of iNSCs using conventional NSC medium {#S3}
-------------------------------------------------

Conventional NSC medium contained DMEM/F12 (Life Technologies) supplemented with 1XB27 and 1XN2 cell-supplements (Life Technologies), 0.01% Fraction V BSA 7.5 % solution (Life Technologies), 1% Penicillin-Streptomycin and 10ng/ml bFGF (R&D) and 20ng/ml mouse EGF (Life Technologies); this media formulation was previously used to generate iNSCs^[@R3]^. We termed this medium "conventional NSC medium" because it does not contain LIF, serum or serum replacement components. For the generation of OKSM-iNSCs, reprogrammable MEFs (rep-MEFs) from mice carrying a *tetOP-OKSM* allele in the *Col1a1* locus and an *M2rtTA* transgene in the *Rosa26* locus^[@R10]^ as well as an *EGFP* transgene knocked into one allele of the *Oct4* locus were used for some of the experiments^[@R10]^. Alternatively, MEFs or tail tips fibroblasts (TTFs) were reprogrammed into iNSCs by infection with lenti-viral vectors expressing *M2rtTA* in combination with either *tetOP-OKSM* or *tetOP-BKSM* cassettes. In conventional NSC medium, at least 8 days (OKSM) or 12 days (BKSM) of dox exposure, followed by 7--21 days (OKSM) and 12--24 days (BKSM) of dox-independent growth, were usually required to generate iNSCs. For most experiments, either 3x10^4^ cells were plated per well of a 6 well plate or 5x10^5^ cells per 10cm plate in MEF medium a day before dox/NSC medium were administered. Of note, low-passage MEFs reprogrammed more efficiently and yielded iNSC colonies faster than high-passage MEFs. Individual iNSC colonies were picked onto Poly-L-Ornithine (P4957, Sigma) coated plates and propagated in conventional NSC medium. For the generation of *Nanog* knockout (KO) iNSCs, *Nanog* KO MEFs were infected with lentiviral vectors expressing *M2rtTA* and *tetOP-OKSM* as previously described^[@R19]^. For each replicate, 3x10^4^ cells were plated per well a day before dox administration. Cells were reprogrammed in conventional NSC medium for 10 days, and then switched to the same NSC medium without dox for an additional 7 days before scoring for Sox1^+^/*CAG-GFP*^+^ transgene-independent iNSC colonies. For the generation of iNSCs from rep-MEFs using small molecules, a concentration of 50 µg/ml ascorbic acid (Sigma) and 3µM GSK3 inhibitor CHIR-99021 (Tocris) were used in conventional NSC medium. For each replicate, 3x10^4^ cells were plated on 6 well plates the day before dox administration. Serum was added for the first 3 days of transdifferentiation to reduce cell death. Small molecules were withdrawn at the same time as dox and as previously described^[@R20]^. A concentration of 2 µg/ml doxycycline (dox) (Sigma) was used for all transdifferentiation and reprogramming experiments.

Generation of iNSCs using modified NSC medium {#S4}
---------------------------------------------

Modified NSC medium contained DMEM/F12, 2% FBS, 8% KOSR (Gibco), 1xN2, 1% Glutamax, 1% NEAA and 0.5% β-mercaptoethanol (all purchased from Life Technologies) and 1000 U/ml LIF (purified in-house). This medium was previously used to generate iNSCs^[@R7]^. We termed this NSC medium "modified" because it contains low levels of serum, KOSR and LIF. To achieve iNSC induction with this medium, MEFs or TTFs were transduced with lentiviral vectors expressing *M2rtTA* and *tetOP-OKSM*. For each replicate, 5x10^5^ cells were plated in a 10cm dish a day before dox administration. OKSM expression was induced by adding dox for 4--5 days in modified NSC medium, followed by 2--4 weeks of dox-independent growth to select for transgene-independent iNSCs. The generation of iNSCs and iPSCs with modified NSC medium required a shorter duration of OKSM expression compared to conventional NSC medium (4 vs. 8 days). Moreover, low-passage MEFs (passage 3 and below) reprogrammed more efficiently and faster than high-passage MEFs. A concentration of 2 µg/ml doxycycline (dox) (Sigma) was used for all transdifferentiation and reprogramming experiments.

Generation of iPSCs in NSC medium {#S5}
---------------------------------

Reprogrammable MEFs or MEFs infected with lentiviral vectors expressing *M2rtTA* and *tetOP-OKSM* were reprogrammed in conventional NSC medium supplemented with dox for 8--12 days to initiate OKSM expression, before switching to ESC medium without dox. Oct4-GFP^+^ colonies were first observed in NSC medium at around day 10--12; however, these cells tended to differentiate into iNSCs after a few days without dox when kept in NSC medium. Switching to ESC medium (serum/LIF) prevented this rapid differentiation and allowed propagation of dox-independent iPSC colonies.

Generation of *Oct4-CreER; Rosa26-loxSTOPlox-EYFP* MEFs {#S6}
-------------------------------------------------------

*Oct4-CreER* mice, termed B6(SJL)-Pou5f1tm1.1(Cre/Esr1\*)Yseg/J, were purchased from Jackson laboratory (Stock number 016829)^[@R15]^. *Oct4-CreER* mice were crossed with *Rosa26-lox-STOP-lox-EYFP* mice^[@R27]^ to produce bitransgenic reporter MEFs and NSCs^[@R27]^. Genotyping of the *Oct4-CreER* allele was performed as previously described^[@R15]^. Cells with the correct genotype were infected with lentiviral vectors harboring *M2rtTA* and *tetOP-OKSM* alleles and reprogrammed in either modified or conventional NSC medium. MEFs carrying the same genotype were used to derive iPSCs in conventional NSC medium (as shown in [Fig. 2](#F2){ref-type="fig"}). 4-hydroxytamoxifen (4-OHT) was used at a concentration of 100nM for all experiments and was continuously added to the culture medium during and after dox treatment to ensure labeling of Oct4^+^ cells at all stages of transdifferentiation. For *in vivo* induction, 1mg tamoxifen (Sigma) was diluted in corn oil (10mg/ml) and injected into the peritoneum of a pregnant mouse at embryonic day E8.5 The brains and gonads of recovered embryos were dissected and analyzed at E13.5.

Derivation of NSCs from fetuses {#S7}
-------------------------------

Brain-derived NSCs were derived from the heads of E13.5 fetuses as previously described^[@R28]^. We used conventional NSC medium for expansion and culture of NSCs.

Scoring for X reactivation during iNSC formation {#S8}
------------------------------------------------

Tail tip fibroblasts (TTFs) obtained from female mice carrying a *CMV-GFP* transgene on one X chromosome^[@R29]^ were infected with lenti-viral vectors carrying the *M2rtTA* and *tetO-OKSM* constructs without dox. Infected cells were sorted twice on a FACSAriaII machine (BD Biosciences) to select for the GFP-negative fraction (sort purity 99.9--100% after 2 sorting rounds). For each replicate, 3x10^4^ cells were sorted a day before dox administration and treated in a 6 well plate. iNSC induction was performed in modified NSC medium in the presence of dox for 4--5 days, followed by 2--4 weeks of dox-independent growth before scoring for the fraction of GFP^+^ Sox1^+^ iNSC colonies.

Retroviral silencing during iNSC induction {#S9}
------------------------------------------

Rep-MEFs were infected with retroviral vectors carrying the pMXs-tdTomato construct. Cells were then sorted on a FACSAriaII machine (BD Biosciences) to isolate the tdTomato^+^ cell-fraction. For each replicate, 3x10^4^ cells were sorted per well of a 6 well plate and cultured in ESC or NSC media supplemented with dox for 12 days. Scoring of iPSC or iNSC colonies was performed 7--10 days after dox withdrawal. iNSC induction was performed in the presence of serum for the first 3 days of OKSM expression to minimize cellular senescence. This modification is in accordance with other reports that used low serum during iNSC induction^[@R4],[@R7]^. Fetal brain-derived NSCs were infected with pMXs-tdTomato retroviral vectors, sorted for the tdTomato^+^ fraction and cultured for an additional 4 weeks in conventional NSC medium before measuring the fraction of tdTomato^+^ NSC spheres.

Generation of *Oct4-CreER; Rosa26-loxSTOPlox-DTA* MEFs {#S10}
------------------------------------------------------

*Oct4-CreER* mice were crossed with *Rosa26-loxSTOPlox-DTA* animals^[@R30]^. MEFs were isolated from bitransgenic fetuses at E13.5. Generation of iNSCs was performed in modified NSC medium. For each replicate, 5x10^5^ cells infected with lenti-viral vectors carrying the *M2rtTA* and *tetO-OKSM* constructs were plated on a 10cm plate a day before dox treatment. Dox was administered for 4--5 days, followed by 2--3 weeks of dox-independent growth. 4-OHT was added throughout the transdifferentiation protocol at a concentration of 100nM for all experiments.

Generation of induced neuronal (iN)-like cells from MEFs {#S11}
--------------------------------------------------------

*Oct4-CreER; R26-lsl-EYFP* MEFs were infected with *tetOP-Brn2, tetOP-Ascl1*, *tetOP-Myt1l* and *M2rtTA* and reprogrammed as described previously^[@R21]^. Dox was added to the medium for 12 days, followed by 7 days of dox-independent growth before measuring Tuj1^+^ iN cells. 4-OHT was used at a concentration of 100nM for all experiments.

Subcloning of iNSC clones {#S12}
-------------------------

OKSM-iNSCs (EYFP^+^) derived from *Oct4-CreER; R26-lsl-EYFP MEFs* were plated at 50 cells per 6 well plate using a FACSAriaII sorter (BD Biosciences). Clonal colonies were detected 7--10 days after plating. Subclones were picked onto poly-ornithine coated plates and propagated until passage 25.

Generation of induced cardiomyocytes {#S13}
------------------------------------

*Oct4-CreER; R26-lsl-EYFP* MEFs were infected with lentiviral vectors expressing *M26rtTA* and *tetOP-OKSM* and treated precisely as reported previously to generate induced cardiomyocytes^[@R2]^. For each replicate, 5x10^5^ cells were plated on a 10cm plate the day before dox exposure to initiate transdifferentiation. Briefly, cells were first cultured in KO-DMEM (Life Technologies) supplemented with 15% FBS, 5% KOSR, 1% Glutamax, 1% non-essential amino acids, 1% penicillin-streptomycin and 1% β-mercaptoethanol. After 6 days of growth in this culture condition, cells were switched to medium containing KO-DMEM supplemented with 14% KOSR, 1% FBS, 1% Glutamax , 1% non-essential amino acids, 1% penicillin-streptomycin, 1% β-mercaptoethanol. During these 9 days, JAK inhibitor (EMD) was added to the medium at a concentration of 0.5µM. At day 9, cells were switched to "CDM medium"^[@R2]^ containing RPMI-1640 (Life Technologies), 0.5 XN2, 1XB27, 0.05% BSA fraction V, 1% Glutamax and 0.5% β-mercaptoethanol. 20ng/ml BMP4 (Stemgent) was added for the first 5 days of culture in CDM medium as previously described^[@R2]^. Dox was administered for 6--9 days for all experiments. iPSC-like colonies appeared 3--4 days after dox withdrawal whereas contracting induced cardiomyocytes were first detected 7--8 days after dox withdrawal. Beating colonies could be detected as long as 3--4 weeks after dox withdrawal. Scoring of induced cardiomyocytes was performed by counting the fraction of EYFP^+^ colonies that showed rhythmic contractions or by co-immunostaining with antibodies against Cardiac Troponin (cTnT) and EYFP 1--2 weeks after dox withdrawal. 4-OHT was used at a concentration of 100nM for all experiments.

Viral vector production {#S14}
-----------------------

For retroviral generation, approximately 2x10^6^ T-293 cells were transfected with 4.5 µg PCL-ECO (ecotropic envelope) and 4.5 µg pMXs-tdTomato vectors, mixed in transfection solution consisting of 300µL Opti-MEM (Gibco) and 27µl of TransIT®-LT1 (Mirus). Transfection was performed in regular MEF medium without Penicillin-Streptomycin. 24 hours post transfection, medium was replaced, and 48 and 72 hours post transfection the supernatant was collected, filtered through a 0.45µM filter (Westnet), supplemented with 4--8 µg/ml Polybrene (Sigma) and added freshly to the cells. For lentiviral generation, ∼6x10^6^ T-293 cells were transfected in a 10cm culture dish with a solution consisting of 770µL Opti-MEM and 50 µl of TransIT®-LT1, Δ8.9 (8.5 µg), VSV-G (5.5 µg) and 11µg of the target plasmid (either *M2rtTA^[@R11]^, tetOP-OKSM^[@R11]^, tetOP-BKSM, tetOP-Ascl1^[@R21]^, tetOP-Brn2^[@R21]^* and *tetOP-Myt1l^[@R21]^*). Viral supernatant was harvested 48 and 72 hours post transfection, filtered and added freshly to the cells. Similar ratios of *M2rtTA* and *tetOP-OKSM* or *tetOP-BKSM* (1:1) were used for maximal infection efficiency.

Construction of the *BKSM* polycistronic expression vector {#S15}
----------------------------------------------------------

To achieve co-expression of *Brn4*, *Klf4*, *Sox2* and *cMyc*, a novel lentiviral construct ("*BKSM*") was generated by reengineering the *STEMCCA* reprogramming vector^[@R18]^. First, a DNA fragment consisting of the *Oct4 (Pou5f1)* gene followed by an F2A peptide and part of the *Klf4* gene was excised from *STEMCCA* (*OKSM*) using NotI and BstZ17I. Next, we used AccuPrimeTM Pfx DNA Polymerase (Life Technologies) to generate a fragment corresponding to *Brn4*-F2A-*Klf4* by overlapping PCR. To accomplish this, two separate reactions were performed using the primer pairs *Brn4* 5' NotI/*Brn4*-F2A 3' and F2A-*Klf4* 5'/*Klf4* 3' BstZ17I (see below) under the following cycling conditions: initial denaturation at 95°C for 2 minutes followed by 35 cycles of 15 seconds at 95°C and 1 minute at 68°C. Aliquots of the two purified amplicons were then mixed in a 1:1 ratio and used in a third PCR with primers *Brn4* 5' NotI and *Klf4* 3' BstZ17I under the following conditions: initial denaturation at 95°C for 2 minutes; 5 cycles of 15 seconds at 95°C, 30 seconds at 58°C, and 2 minutes at 68°C; and 30 cycles of 15 seconds at 95°C, 30 seconds at 63°C, and 2 minutes at 68°C. The resulting fragment (*Brn4*-F2A-*Klf4*) was gel-purified, digested and inserted by directional cloning into the NotI- and BstZ17I-digested *STEMCCA* lentiviral vector. We confirmed the identity of the *BKSM* polycistronic vector by restriction analysis; DNA sequencing and immunostaining (see [supplementary data](#SD1){ref-type="supplementary-material"}). The primer sequences used were: Brn4 5' NotI: ATAAGAATGCGGCCGCCATGGCCACAGCTGCCTCGAATCCCTACBrn4-F2A 3': CTTGAGAAGGTCAAAATTCAAAGTCTGTTTCACGCCACTTCCGAG ATCGTGGCA GGACGCGTCTGTTTTCACCF2A-Klf4 5': AAACAGACTTTGAATTTTGACCTTCTCAAGTTGGCGGGAGACGTGGAGTCCAACCCAGGGCCCATGGCTAGCGACGCTCTGCTCCCKlf4 3' BstZ17I: TCTTTCGTATACTGGGTCCAACTCCGGCCGCAGGAGC

Differentiation potential of iNSCs {#S16}
----------------------------------

To generate neurons, OKSM-iNSCs were grown in NSC medium following removal of the growth factors bFGF and EGF for 5--10 days; neuronal cells were identified by immunostaining with rabbit anti-Tuj1 antibody (Covance, IgG1, 1:200). Astrocytes were generated using NSC medium supplemented with 5% FBS for a duration of 10 days, after which they were stained with rabbit anti-GFAP antibody (Dako Z0334, IgG, 1:200). The secondary antibody used was donkey anti-rabbit IgG (A10040, Alexa Fluor 546) at a concentration of 1:250. See "Immunocytochemistry" section for a detailed protocol.

Immunocytochemistry {#S17}
-------------------

Cells were washed twice with 1xPBS, cross-linked in 4% PFA solution for 5--10 minutes, washed with 1xPBS and blocked for ½ hour at room temperature (RT) with blocking solution (2% BSA dissolved in PBS and 0.1% Triton-X-100). Primary antibody staining was performed at RT (1 hour). Appropriate secondary antibodies were added after two washes with 1xPBS, followed by incubation for 1 hour at RT. Primary and secondary antibodies were diluted in blocking solution. DAPI was used for nuclear counterstaining. The following antibodies were used in this study: rabbit anti-Nanog (AB80892 Abcam, IgG, 1:200), goat anti-Oct4 (Santa Cruz sc-8628, IgG 1:200), goat anti-Sox1 (R&D, AF3369, 1:100), goat anti-Sox2 (Santa Cruz sc-17320, IgG, 1:200), mouse anti-Nestin (Abcam AB6142, IgG1, 1:200), goat anti-Glast1/Eaat1 (Santa Cruz SC-7757, IgG, 1:200) , rabbit anti-Brn4/Pou3f4 (Millipore, IgG, 1:200) chicken anti-GFP/EYFP (AVES, 1:300, GFP-1020) and anti-mouse cardiac troponin (cTnT) (DSHB, CT3, 1:1000). Secondary antibodies used were A11056 Alexa Fluor 546 donkey anti-goat IgG, A21123 Alexa Fluor 546 goat anti-mouse IgG1, A10040 Alexa Fluor donkey anti-rabbit IgG and A11055 Alexa Fluor 488 donkey anti-goat IgG, all at a 1:250 dilution. 488 goat anti-chicken IgG (A-11039, Life technologies,) or Rabbit anti chicken IgY (F4137, Sigma) were used at a dilution of 1:1000. We employed anti-EGFP/EYFP antibodies to stain for EYFP when co-immunostaining colonies for Sox1 or cTnT since the endogenous EYFP protein is quenched by PFA treatment during the immunostaining protocol.

Antibody live staining {#S18}
----------------------

For live staining of cells, PE-conjugated anti-mouse PeCAM1 (CD31) antibody (12--031182 eBioscience, 1:200) or PE-conjugated anti-mouse CD326 EpCAM (clone G8.8 12--5791-83, eBioscience 1:200) were added directly to the cells. Cells were then incubated at 37C for an hour, washed twice with 1xPBS and visualized for surface marker expression.

Flow cytometry analysis of surface markers {#S19}
------------------------------------------

Cells were harvested using 0.25% trypsin and resuspended in 1xPBS buffer containing 2% FBS ("FACS buffer"). The appropriate conjugated antibodies were added at similar ratios (1:200); anti-mouse PE-conjugated CD326 EpCAM (1:200, eBioscience) and anti-mouse eFluor 450-conjugated CD90 Thy1.2 (1:200, eBioscience). Cells were incubated on ice for 20 minutes, washed in 1xPBS, resuspended in FACS buffer, filtered and then analyzed on a MACSQuant flow cytometer (Miltenyi Biotec). Analysis was performed using the software FlowJo.

RNA extraction and microarrays {#S20}
------------------------------

RNA (DNase-treated) was extracted using RNAeasy Mini Kit (Qiagen) according to the manufacturer's instructions and subjected to hybridization to the GeneChip Mouse 2.0 ST arrays (Affymetrix) at the Partners Center for Personalized Genetic Medicine. Expression Console (Affymetrix) was used for RMA. Hierarchical clustering and dendrogram analysis were performed using Expander software (EXPression Analyzer and DisplayER). Scatter plot, analysis of linear regression coefficients and TTEST analysis were performed using Excel. Classification and annotations of upregulated genes were performed using the DAVID online functional annotation tool (<http://david.abcc.ncifcrf.gov/>). RNA was extracted from expanded OKSM or BKSM-iNSC clusters that have been propagated for several passages. Expression data for MEFs and pluripotent stem cells were previously published^[@R20]^. The microarray data has been deposited in NCBI Gene Expression Omnibus (GEO) under accession number GSE65951.

Alkaline phosphatase staining {#S21}
-----------------------------

To detect iPSC colonies, alkaline phosphatase kit (Vector Labs) was used according to the manufacturer's recommendations.

Teratoma formation {#S22}
------------------

Approximately 2x10^6^ BKSM-iPSCs were injected under the flanks of SCID-beige mice. 3--4 weeks post-injection, mice were sacrificed to harvest tumor masses. Paraffin section and hematoxylin and eosin (H&E) staining were performed at the Brigham and Women's Hospital pathology core.

Generation of chimeric mice {#S23}
---------------------------

Chimeras were generated by blastocyst injections as described previously^[@R20]^. Briefly, superovulation was initiated by injecting five female B6D2F1/J mice (Jackson Laboratory) with pregnant mare serum (Sigma) by intraperitoneal injection. Two days later, human chorionic gonadotropin (Sigma) was administered via intraperitoneal injection, and female mice were mated with B6D2F1/J males. After three days, developing blastocysts were collected and injected with the indicated cell types. Injected blastocysts were transplanted into the uterus of pseudo-pregnant Swiss Webster female mice (Jackson Laboratory; approximately 2 months of age) and allowed to develop to midgestation or term. All procedures involving animals were performed according to a mouse protocol approved by the MGH Subcommittee on Research Animal Care.

Allele-specific real-time PCR for X-linked marker gene {#S24}
------------------------------------------------------

DNase-treated RNA was extracted using the RNAeasy Mini Kit (Qiagen) according to the manufacturer's instructions. Conversion of RNA to cDNA was performed using the Transcriptor First Strand cDNA Synthesis Kit (Roche) as per manufacturer's instructions. mRNA levels were measured using Brilliant iii SybrGreen kit (Agilent) on a Stratagene Mx3005P qRT-PCR system (Agilent). mRNA levels were normalized to GAPDH. We used the following primer sequences for qRT-PCR: Uba1 129/mus musculus-specific primer -- TGAGCTCCTCAAGACGGCAG. Uba1 mus castaneous-specific primer -- TGAGCTCCTCAAGACGGCCA. Common Uba1 reverse primer - CCTTTTTGCCCAGACCTATF.

Supplementary Material {#SM}
======================

Accession codes: NCBI Gene Expression Omnibus (GEO): microarray data have been deposited under accession number GSE65951.
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![Generation of iPSCs and iNSCs under neural culture conditions\
**(A)** Experimental design to generate iPSCs and iNSCs in different culture conditions using reprogrammable MEFs (rep-MEFs) harboring the *Col1a1-tetOP-OKSM* and *Rosa26-M2rtTA* alleles and an *Oct4-GFP* reporter. **(B)** Representative image of Oct4-GFP^+^ iPSC colony generated in ESC medium (serum + LIF) (upper panel) and Oct4-GFP iNSC-like colony generated in NSC medium (−LIF/+FGF, EGF) showing typical spheroid morphology with neurite-like structures projecting from the center (bottom panel). Scale bar is 250µM. **(C)** Representative immunoﬂuorescence images showing staining for indicated NSC markers in brain-derived NSCs and OKSM-iNSCs. MEFs served as a negative control. Scale bar is 100µM. **(D)** Expression of NSC or MEF-associated markers in the indicated cell lines based on microarray gene expression analysis. **(E)** Differentiation potential of OKSM-iNSCs into Tuj1^+^ neurons and GFAP^+^ astrocytes. Scale bar is 100µM. **(F)** Representative immunoﬂuorescence image of a Sox1^+^ iNSC colony obtained after 10 days of OKSM expression, followed by 9 days of dox-independent growth. Scale bar is 100µM. Autofluor., autofluorescence control. **(G)** Graph showing the minimal number of days required to generate stable Sox1^+^ iNSC colonies using conventional NSC medium. Doxycycline was applied for indicated lengths of time before scoring for iNSC colonies at day 19 to capture stable, transgene-independent colonies. For each replicate, 3x10^4^ cells were used (n=3 independent replicates for each time point; error bars, standard error of the mean (s.e.m.) for 3 independent experiments). **(H)** Detection of a rare Oct4-GFP^+^ iPSC-like colony under transdifferentiation conditions in NSC medium. Scale bar is 100µM. **(I)** Flow cytometric analysis for Oct4-GFP expression in bulk rep-MEF cultures subjected to the NSC transdifferentiation protocol. The PE-Cy7 channel was used to detect autofluorescence. **(J)** Contribution of NSC medium--derived iPSCs to chimeras as indicated by agouti coat color (upper image). Germline offspring (white arrowheads) obtained from a male chimera (red arrow) (lower image). **(K)** Potential of sorted SSEA1^+^/EpCAM^+^ and SSEA1^+^/EpCAM intermediates after 6 days of OKSM expression to produce iPSCs in ESC medium or iNSCs in conventional NSC medium, respectively. For each replicate, 10x10^5^ cells were plated (n=3 independent replicates; error bars, s.e.m for 3 independent experiments, \*p\<0.05). **(L)** Representative images of an Oct4-GFP^+^ colony (top image) and a Sox1^+^ iNSC colony (bottom image) obtained from sorted SSEA1^+^/EpCAM^+^ intermediates (day 6) in NSC medium. White arrowheads indicate an Oct4-GFP colony (top) or clusters of Sox1^+^ expressing cells (bottom). Scale bar is 500µM (Oct4-GFP) or 250µM (Sox1). **(M)** Quantification of Oct4-GFP^+^ colonies, Oct4-GFP^+^/iNSC hybrid colonies and Oct4-GFP/iNSC colonies at the indicated time points after dox withdrawal (w/d). For each replicate, 3x10^4^ cells were used (n=3 independent replicates for each time point; error bars, s.e.m. for 3 independent experiments). **(N)** Representative image of iPSC/iNSC hybrid colonies detected during the transdifferentiation protocol. Note the dome-shaped iPSC-like colonies in the center and emanating neurites (indicated by black and red arrowheads, respectively). Bottom images shows patches of *Oct4-GFP* reporter expression (white arrowheads) within the same colony as shown above. Scale bar is 250µM. Insets show magnification of neurites (top) and a representative Oct4-GFP colony (bottom).](nihms681927f1){#F1}

![Oct4 lineage tracing and ablation during iNSC induction\
**(A)** Schematic showing lineage tracing approach to test whether iNSCs pass through an *Oct4^+^* state. **(B)** Head and gonads from an *Oct4-CreER; R26-lsl-EYFP* embryo that was induced in utero with 4-OHT (E8.5) and recovered at E13.5. Note that the brain is EYFP negative, while the gonads are EYFP positive, indicating specificity of the lineage-tracing allele *in-vivo*. **(C)** Generation of *EYFP^+^* iPSCs from *Oct4-CreER; R26-lsl-EYFP* MEFs generated in NSC medium. Note that iPSCs are EYFP^+^ only when 4-OHT is administered to the reprogramming medium. Scale bar is 250µM. Autofluor., autofluorescence control. **(D)** Representative immunoﬂuorescence images for the indicated pluripotency markers in NSC medium--derived EYFP^+^ iPSCs. Scale bar is 100µM. **(E)** EYFP^+^ iPSCs, derived in NSC medium, contribute to an E13.5 midgestation chimera (upper images); non-chimeric littermate lacks EYFP signal (bottom images). **(F)** Images of EYFP^+^ OKSM-iNSC colonies with typical neurites protruding from the center. OKSM-iNSC colonies remain EYFP when 4-OHT is not applied. Scale bar is 500µM. **(G)** Quantification of Sox1^+^ EYFP^+^ and Sox1^+^ EYFP iNSC colonies generated in conventional NSC medium after 8--12 days of OKSM induction, followed by 14--18 days of dox-independent growth. For each replicate, 3x10^4^ cells were used (n=3 biological replicates; error bars, s.e.m. for 3 independent experiments, \*p\<0.05). A representative EYFP^+^ iNSC colony with patches of Sox1^+^ expressing cells is shown to the left. Scale bar is 100µM. **(H)** Immunofluorescence for EYFP of OKSM-iNSC subclone \#1 at passage 20, demonstrating continuous and uniform EYFP expression. Scale bar is 100µM. **(I)** Flow cytometric analysis for EYFP expression of the same OKSM-iNSC subclone \#1. The PE-Cy7 channel was used to control for autofluorescence. **(J)** Quantification of Sox1^+^ EYFP^+^ and Sox1^+^ EYFP iNSC colonies, generated in modified NSC medium after 4--5 days of OKSM induction, followed by 2--4 weeks of dox-independent growth. For each replicate, 5x10^5^ cells were used (n=3 biological replicates; error bars, s.e.m. for 3 independent experiments, \*\*\*p\<0.0005). A representative EYFP^+^/Sox1^+^ iNSC colony is shown to the left. Scale bar is 100µM. **(K)** Quantification of Sox1^+^ iNSC colonies obtained from *Oct4-CreER; R26-lsl*-DTA (Diphtheria Toxin fragment A) MEFs after 5 days of OKSM expression, followed by 3 weeks of dox-independent growth in modified NSC medium in the absence or presence of 4-OHT. For each replicate, 5x10^5^ cells were used (n=3 independent replicates; error bars, s.e.m. for 3 independent experiments, \*p\<0.05). Scale bar is 100µM. Autofluor., autofluorescence. Representative images are shown to the left.](nihms681927f2){#F2}

![Silencing of retroviral transgenes and X chromosome reactivation during iNSCs induction\
**(A)** Experimental design to assess retroviral silencing during iNSC formation. **(B)** Representative images comparing tdTomato expression in MEFs, iPSCs, OKSM-iNSCs and brain-derived NSCs. Note that tdTomato^+^ non-reprogrammed MEFs surround the iPSC and iNSC colonies. Scale bar is 250µM. **(C)** Quantification of iNSC colonies expressing tdTomato^+^. For each replicate, 3x10^4^ cells were used (n=5 independent replicates; error bars, s.e.m. for 5 independent experiments, \*p\<0.05). **(D)** Experimental design to follow X chromosome inactivation status during iNSC formation. Tail tip fibroblasts (TTFs) from a female mouse heterozygous for an X-linked *CMV-GFP* reporter (mix of Xi^GFP^Xa and XiXa^GFP^ cells) were sorted twice for cells that carried the GFP transgene on the inactive X chromosome (Xi^GFP^Xa). These cells were reprogramed for 4--5 days in modified NSC medium, after which dox was withdrawn and GFP expression was assessed in emerging Sox1^+^ iNSC colonies 2--4 weeks later. **(E)** Representative immunoﬂuorescence images of Sox1^+^ iNSC colonies that show reactivation of the silent Xi^GFP^ reporter. Scale bar is 250µM. **(F)** Quantification of Sox1^+^ iNSC colonies that reactivated the silenced X chromosome as determined by GFP reporter reactivation. All examined Sox1^+^ iNSC colonies showed patchy GFP expression. For each replicate, 3x10^4^ cells were used (n=3 independent replicates; error bars, s.e.m. for 3 independent experiments, \*\*\*p\<0.0005). **(G)** Representative immunoﬂuorescence images showing *Nanog* knockout Sox1^+^ iNSC colony generated in the presence of ascorbate. *Nanog*-deficient iNSCs express the constitutive *CAG-GFP* marker, confirming their origin from *Nanog*-mutant MEFs. Scale bar is 100µM. Autofluor., autofluorescence control. **(H)** Quantification of Sox1^+^ iNSC colonies generated from *Nanog*-deficient MEFs with and without ascorbate. For each replicate, 3x10^4^ cells were used (n=3 independent replicates; error bars, s.e.m. for 3 independent experiments, \*\*p\<0.005).](nihms681927f3){#F3}

![An alternative transdifferentiation cocktail generates iNSCs and iPSCs via an Oct4^+^ intermediate stage\
**(A)** Replacement of the *Oct4* gene within the *Oct4-Klf4-Sox2-cMyc* (*OKSM* cassette) by the neuronal transcription factor Brn4 (*BKSM* cassette). **(B)** Experimental design to generate iPSCs and iNSCs using the *BKSM* cassette from MEFs harboring a *Sox2-GFP* knock-in allele in ESC or NSC culture conditions. **(C)** Immunoﬂuorescence of typical NSC markers in an expanded BKSM-iNSC clone. Scale bar is 100µM. **(D)** Expression of selected NSC-associated genes in indicated cell lines based on microarray data. Microarray analysis was performed on expanded clonal iNSC cultures. **(E)** Immunoﬂuorescence for indicated pluripotency markers in expanded BKSM-iPSC clone. Scale bar is 250µM. **(F)** Dendrogram based on microarray analysis of indicated samples. Note that BKSM-iNSCs and OKSM-iNSCs cluster with brain-derived NSCs while BKSM-iPSCs cluster with mouse ESCs. **(G)** Contribution of BKSM-iPSCs to an adult chimera as shown by agouti coat color. **(H)** Representative images of EYFP^+^ BKSM-iNSC colonies with emanating neurites generated from MEFs in conventional NSC medium. Scale bar is 500µM for iNSC colony (left) and 100µM for neurites (right). Autofluor., autofluorescence control. **(I)** Quantification of EYFP^+^ BKSM-iNSC colonies, demonstrating that all of the examined BKSM-iNSC colonies transitioned through an *Oct4^+^* state. For each replicate, 5x10^5^ cells were used (n=3 biological replicates; error bars, s.e.m. for 3 independent experiments, \*\*p\<0.005). **(J)** Representative images showing EYFP^+^ cells in a cluster of beating cardiomyocytes (red arrowheads). **(K)** Quantification of EYFP^+^, EYFP and EYFP^+^/EYFP contracting induced cardiomyocyte colonies derived from *Oct4-CreER; R26-lsl-EYFP* MEFs upon short OKSM expression in cardiac transdifferentiation conditions. For each replicate, 5x10^5^ cells were used (n=3 biological replicates; error bars, s.e.m. for 3 independent experiments, \*\*p\<0.005). **(L)** Summary.](nihms681927f4){#F4}
